HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

HENGRUI PHARMA

55.150

+11.10025.20%

Volume:82.66M

Turnover:4.73B

Market Cap:364.18B

PE:53.23

High:60.500

Open:57.000

Low:55.150

Close:44.050

Loading ...

Overview Company News Filings

Hong Kong Stocks End Week Higher; Hengrui Pharma, Mirxes Surge in Debut

MT Newswires Live

HK Stocks Close Mixed. Hengrui Pharma Surges 25%; Bilibili up 4.4%; BYD up 2%; Li Auto up 1%

Hengrui Pharma Gets Nod to Market Reglitin-Metformin Tablets

MT Newswires Live

BUZZ-MiRXES, Hengrui Pharmaceuticals soar on Hong Kong debut

Jiangsu Hengrui, Mirxes debuts cap strong week for Hong Kong listings

HK Movers | HK's Pharma Shares Soar. Hengrui Pharma Surges 29%; Asymchem up 7%; CSPC Pharma up 4%

Tiger Newspress

Hengrui Pharma's Hong Kong Listing Nets HK$9.8 Billion

MT Newswires Live

Stock Track | Hengrui Pharma Soars 36% in Hong Kong Debut After Oversubscribed IPO

Shares of Jiangsu Hengrui Set to Open at HK$57 Each in Hong Kong Debut VS Offer Price HK$44.05 Apiece

THOMSON REUTERS

China's Jiangsu Hengrui shares set to rise 29% in Hong Kong listing

Top Chinese Drugmaker Hengrui Set to Begin Hong Kong Trading

A Leading Chinese Developer of Novel Drugs Hengrui Pharma Soars 25% in Hong Kong Grey Market Trading

Tiger Newspress

Hengrui Pharma Prices Hong Kong IPO at Top of Range, Raises HK$9.9 Billion

MT Newswires Live

Hengrui Pharma IPO Said To Be Priced At Upper Limit Of HKD44.05

Hong Kong Shares Snap Three-Day Winning Streak; Gold Shares Slide on Lower Prices

MT Newswires Live

Jiangsu Hengrui Pharmaceuticals Launches Up to HK$9.9 Billion Hong Kong IPO

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/01276/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":55.15,"timestamp":1747987708026,"preClose":44.05,"halted":0,"volume":82663811,"delay":0,"floatShares":224519800,"shares":6603522074,"eps":1.036,"marketStatus":"Not Yet Opened","change":11.1,"latestTime":"05-23 16:08:28","open":57,"high":60.5,"low":55.15,"amount":4733500812,"amplitude":0.121453,"askPrice":55.5,"askSize":2200,"bidPrice":55.15,"bidSize":14200,"shortable":0,"etf":0,"ttmEps":1.036205539,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1748223000000},"marketStatusCode":0,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":44.05,"dividendRate":0.003941,"openAndCloseTimeList":[[1747963800000,1747972800000],[1747976400000,1747987200000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":54.5,"timestamp":1747983600000,"preClose":55.4,"halted":0,"volume":54184000,"delay":0,"premium":"-7.34"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":224519800,"roa":"8.99%","roe":"15.22%","lyrEps":1.036,"shares":6603522074,"dividePrice":0.218423,"high":60.5,"amplitude":0.121453,"preClose":44.05,"low":55.15,"week52Low":55.15,"pbRate":"7.10","psRate":"11.42","week52High":60.5,"institutionHeld":0,"latestPrice":55.15,"committee":0.731707,"eps":1.036,"divideRate":0.003961,"volume":82663811,"delay":0,"ttmEps":1.036205539,"open":57,"prevYearClose":44.05,"prevWeekClose":44.05,"prevMonthClose":44.05,"prevQuarterClose":44.05,"fiveDayClose":44.05,"twentyDayClose":44.05,"sixtyDayClose":44.05},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2537518576","title":"Hong Kong Stocks End Week Higher; Hengrui Pharma, Mirxes Surge in Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2537518576","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537518576?lang=en_us&edition=fundamental","pubTime":"2025-05-23 16:48","pubTimestamp":1747990101,"startTime":"0","endTime":"0","summary":"Hong Kong stocks rose slightly on Friday to close the week in green, buoyed by multiple strong market debuts.The Hang Seng Index edged up 0.2%, or 56.95 points, to end at 23,601.26. The Hang Seng China Enterprises Index rose 0.3%, or 26.22 points, to 8,583.86.Two firms saw a stellar trading debut on the Hong Kong bourse on Friday.Singapore-headquartered micro ribonucleic acid technology company Mirxes Holding  finished at HK$30 per share, up almost 29% from its IPO price of HK$23.30.Jiangsu Hengrui Pharmaceuticals  closed at HK$55.15 per share, up 25% from its IPO price of HK$44.05.Earlier this week, CATL  also made a strong market debut. The battery giant raised over HK$35 billion from its Hong Kong IPO, reportedly the world's largest listing so far this year, according to Reuters.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"92258637d6ff1e9cb4f4844790de8572","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2039709279.SGD","02833","LU2778985437.USD","IE00B543WZ88.USD","LU0106252389.USD","LU2298064838.USD","MHImain","LU0359201612.USD","LU2580892789.USD","LU0128522157.USD","HHImain","LU0516423091.SGD","LU2097828557.USD","LU1781817850.SGD","BK0060","LU0823414478.USD","LU0164865239.USD","LU0348805143.USD","LU2242644610.SGD","LU0455707207.USD","HSI","LU2476274720.SGD","LU1064131003.USD","LU2148510915.USD","BK0183","IE0003851619.USD","LU1051769294.HKD","02629","LU1880383366.USD","LU1979443071.USD","EVS.SI","LU2153591404.USD","LU1813983027.USD","513600","LU1023057109.AUD","LU1997245177.USD","BK0188","01276","MCHmain","LU0607220059.USD","LU0047713382.USD","LU1969619763.USD","LU0449509016.USD","SG9999001846.SGD","LU1580142542.USD","600276","IE00BPRC5H50.USD","LU1769817096.USD"],"gpt_icon":1},{"id":"1133975578","title":"HK Stocks Close Mixed. Hengrui Pharma Surges 25%; Bilibili up 4.4%; BYD up 2%; Li Auto up 1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133975578","media":"Market Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133975578?lang=en_us&edition=fundamental","pubTime":"2025-05-23 16:27","pubTimestamp":1747988839,"startTime":"0","endTime":"0","summary":"On May 23, 2025, the Hong Kong stock market closed with slight gains. The Hang Seng Index rose 0.06%, the National Enterprise Index increased by 0.10%, the Hang Seng Technology Index was up 0.07%. In the pharmaceutical sector, Hengrui Pharma made a significant impact with its global offering of 224.5 million shares at HK$44.05 per share, raising net proceeds of HK$9.7473 billion. The Hong Kong public offering was oversubscribed by 454.85 times, and the international offering by 17.09 times. Heng","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"cba27cebe35c2f39634f031301bd1605","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09868","HSI","HSTECH","09626","HSCEI","01211","03750","01276","02015","09988","01810"],"gpt_icon":0},{"id":"2537812908","title":"Hengrui Pharma Gets Nod to Market Reglitin-Metformin Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2537812908","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537812908?lang=en_us&edition=fundamental","pubTime":"2025-05-23 11:12","pubTimestamp":1747969924,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  received a drug registration certificate from China's National Medical Products Administration to market Reglitin-Metformin Tablets /, according to a Shanghai Stock Exchange filing on Thursday.The drug is indicated to improve glycemic control in adult patients with type 2 diabetes, who are suitable for treatment with phosphate reglitin and metformin hydrochloride.This product is China's first independently developed fixed-dose combination formulation of a dipeptidyl peptidase-4 inhibitor with metformin, the disclosure said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01276","BK0188","LU1064130708.USD","BK0060","LU1969619763.USD","BK0239","LU1064131003.USD","BK0196","BK0028","BK0012","LU0405327494.USD","LU2488822045.USD","BK0183","LU2148510915.USD","LU1328615791.USD","600276","LU0405327148.USD","LU2328871848.SGD"],"gpt_icon":1},{"id":"2537703159","title":"BUZZ-MiRXES, Hengrui Pharmaceuticals soar on Hong Kong debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2537703159","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537703159?lang=en_us&edition=fundamental","pubTime":"2025-05-23 10:46","pubTimestamp":1747968388,"startTime":"0","endTime":"0","summary":"BUZZ-MiRXES, Hengrui Pharmaceuticals soar on Hong Kong debut** MiRXES Holding 2629.HK climbs to HK$31.95 on HK debut, up 37.1% from offer price of HK$23.30** Stock last up 31.8%, outpacing Hang Seng Index's .HSI 0.5% gain and Hang Seng Biotech index's .HSHKBIO 2.3% jump** Singapore-headquartered micro ribonucleic acid  tech co, which specialises in early cancer detection and precision medicine, sells 46.6 mln shares in global offering, raising HK$1.09 bln  for R&D, manufacturing, commercialisation of core product** Jiangsu Hengrui Pharmaceuticals 1276.HK jumps to HK$60.5 on HK debut, up 37.3% from offer price of HK$44.05** Chinese oncology drug developer sells 224.52 mln H-shares, raising HK$9.89 bln  for R&D, constructing  production facilities** Hengrui's Shanghai stock 600276.SS slips 1.6%  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"92258637d6ff1e9cb4f4844790de8572","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nL1N3RV01T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1051768304.USD","LU1064131003.USD","02629","LU2148510915.USD","BK0239","LU0651946864.USD","BK0275","01276","LU0405327148.USD","LU1515016050.SGD","BK0187","BK0012","BK0006","BK0176","BK0274","LU1580142542.USD","BK0188","BK0025","LU2488822045.USD","BK0000","BK0060","LU2328871848.SGD","600276","LU1969619763.USD","600688","LU1781817850.SGD","600028","BK0010","LU0405327494.USD","BK0196","BK0183","LU1064130708.USD","BK0015","BK0028","LU1328615791.USD"],"gpt_icon":1},{"id":"2537778869","title":"Jiangsu Hengrui, Mirxes debuts cap strong week for Hong Kong listings","url":"https://stock-news.laohu8.com/highlight/detail?id=2537778869","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537778869?lang=en_us&edition=fundamental","pubTime":"2025-05-23 10:17","pubTimestamp":1747966636,"startTime":"0","endTime":"0","summary":"UPDATE 2-Jiangsu Hengrui, Mirxes debuts cap strong week for Hong Kong listingsHong Kong sees $6.5 billion in new listings this weekHong Kong IPOs and listings have best start to year since 2021 - LSEG dataDemand strong despite US-China geopolitical tensionsHang Seng Index up 18% in 2025, boosting market activityRecasts, updates share prices, adds Jiangsu Hengrui deal details and comments from paragraphs 8-13By Scott Murdoch and Donny Kwok. HONG KONG, May 23  - Positive trading debuts on Friday for Jiangsu Hengrui Pharmaceuticals 1276.HK and Mirxes Holdings 2629.HK, which raised a combined $1.4 billion in separate listings, capped one of the strongest weeks for Hong Kong's capital markets in the past year.\"While the pipeline for the rest of the year is strong and more high-quality names are looking to list across the region, companies will need to be cognizant of the global market environment and be tactical around windows to come to market","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nL1N3RV01G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","LU1969619763.USD","LU1064131003.USD","LU2488822045.USD","BK0012","02629","LU1328615791.USD","600276","LU1064130708.USD","01276","BK0028","BK0196","BK0239","LU0405327494.USD","LU0405327148.USD","LU2328871848.SGD","LU2148510915.USD","BK0183","BK0188"],"gpt_icon":1},{"id":"1133424631","title":"HK Movers | HK's Pharma Shares Soar. Hengrui Pharma Surges 29%; Asymchem up 7%; CSPC Pharma up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133424631","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133424631?lang=en_us&edition=fundamental","pubTime":"2025-05-23 10:09","pubTimestamp":1747966164,"startTime":"0","endTime":"0","summary":"Hong Kong’s pharma stocks rose on Friday.Hengrui Pharma surged 29%; Asymchem rose 7%; CSPC Pharma rose 4%; Hutchmed, Innovent Bio, Laekna rose 3%; CanSinoBIO rose 2%.Hengrui, which is based in eastern China’s Jiangsu province, began operations in 1970 as state-owned Lianyungang Pharmaceutical Factory. It listed in Shanghai in 2000.Over the years, it has shifted focus to developing novel drugs from making generic medicines. It has spent 44 billion yuan  on R&D since 2000, according to its website","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"97c4ce10e0d7371cbbe9d36dff321fe2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093","00013","06185","02105","06821","01276","01801"],"gpt_icon":1},{"id":"2537972586","title":"Hengrui Pharma's Hong Kong Listing Nets HK$9.8 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2537972586","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537972586?lang=en_us&edition=fundamental","pubTime":"2025-05-23 09:59","pubTimestamp":1747965576,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  priced its initial public offering in Hong Kong at the upper limit of its indicative range to raise HK$9.75 billion in net proceeds.The Chinese drugmaker issued 224.5 million shares at HK$44.05 each, the top end of its guidance of as low as HK$41.45 per share, according to a Thursday filing with the Hong Kong Exchange.The deal's Hong Kong public offering portion was 454.9 times subscribed, prompting the company to issue 48.3 million shares, a near fourfold increase from the 12.3 million shares initially allotted.The international offering portion was 17.1 times subscribed, and the firm issued 176.2 million shares, lower than the initial allocation of 212.2 million.The cornerstone investors, including Singaporean sovereign wealth fund GIC, subscribed to a total of 93.7 million IPO shares.Hengrui Pharma starts trading on the Hong Kong bourse today, May 23.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"92258637d6ff1e9cb4f4844790de8572","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0188","BK0239","LU2488822045.USD","BK0183","BK0060","LU0405327494.USD","BK0012","BK0028","LU0405327148.USD","LU1064130708.USD","LU1064131003.USD","LU1969619763.USD","LU2148510915.USD","LU2328871848.SGD","01276","BK0196","LU1328615791.USD","600276"],"gpt_icon":1},{"id":"1125632370","title":"Stock Track | Hengrui Pharma Soars 36% in Hong Kong Debut After Oversubscribed IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1125632370","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125632370?lang=en_us&edition=fundamental","pubTime":"2025-05-23 09:33","pubTimestamp":1747964011,"startTime":"0","endTime":"0","summary":"Shares of Jiangsu Hengrui Pharmaceuticals Co. , China's largest drugmaker by market value, skyrocketed 36.32% in their Hong Kong stock market debut on Friday. The stellar performance came after the company raised HK$9.9 billion  in a highly anticipated initial public offering .The strong debut was fueled by overwhelming investor demand. Hengrui's Hong Kong public offering was oversubscribed by an impressive 454.85 times, while the international offering saw 17.09 times oversubscription. The comp","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"92258637d6ff1e9cb4f4844790de8572","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01276"],"gpt_icon":1},{"id":"2537629971","title":"Shares of Jiangsu Hengrui  Set to Open at HK$57 Each in Hong Kong Debut VS Offer Price HK$44.05 Apiece","url":"https://stock-news.laohu8.com/highlight/detail?id=2537629971","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537629971?lang=en_us&edition=fundamental","pubTime":"2025-05-23 09:20","pubTimestamp":1747963227,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nL4N3RV02V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1064131003.USD","LU2148510915.USD","LU1064130708.USD","LU2488822045.USD","BK0239","LU0405327148.USD","BK0196","BK0060","LU1328615791.USD","BK0028","BK0183","LU1969619763.USD","600276","01276","LU0405327494.USD","BK0012","LU2328871848.SGD","BK0188"],"gpt_icon":0},{"id":"2537461971","title":"China's Jiangsu Hengrui shares set to rise 29% in Hong Kong listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2537461971","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537461971?lang=en_us&edition=fundamental","pubTime":"2025-05-23 09:20","pubTimestamp":1747963227,"startTime":"0","endTime":"0","summary":"China's Jiangsu Hengrui shares set to rise 29% in Hong Kong listingSYDNEY, May 23  - Shares of Chinese pharmaceutical company Jiangsu Hengrui 1276.HK are set to rise 29% in its Hong Kong debut on Friday, after finalising its $1.27 billion listing.  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nL4N3RV02V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2328871848.SGD","LU1064130708.USD","LU1969619763.USD","BK0239","LU1064131003.USD","LU2488822045.USD","BK0060","BK0012","BK0028","600276","LU0405327494.USD","LU0405327148.USD","LU1328615791.USD","BK0188","01276","BK0196","LU2148510915.USD","BK0183"],"gpt_icon":0},{"id":"1160323837","title":"Top Chinese Drugmaker Hengrui Set to Begin Hong Kong Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1160323837","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160323837?lang=en_us&edition=fundamental","pubTime":"2025-05-23 08:01","pubTimestamp":1747958488,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., China’s largest drugmaker by market value, is set to begin trading in Hong Kong Friday after raising HK$9.9 billion ($1.3 billion) as listings pick up in the Asian","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bloomberg.com/news/articles/2025-05-22/top-chinese-drugmaker-hengrui-set-to-begin-hong-kong-trading","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1584095487587","symbols":["01276"],"gpt_icon":1},{"id":"1182758731","title":"A Leading Chinese Developer of Novel Drugs Hengrui Pharma Soars 25% in Hong Kong Grey Market Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1182758731","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182758731?lang=en_us&edition=fundamental","pubTime":"2025-05-22 16:15","pubTimestamp":1747901752,"startTime":"0","endTime":"0","summary":"A leading Chinese developer of novel drugs $HENGRUI PHARMA(01276)$ shares surged 25% in Hong Kong grey market trading.The Chinese pharmaceutical giant, founded in 1970 and specializing in oncology, me","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"97c4ce10e0d7371cbbe9d36dff321fe2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"A Leading Chinese Developer of Novel Drugs Hengrui Pharma Soars 25% in Hong Kong Grey Market Trading","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"gpt_icon":0},{"id":"2537981750","title":"Hengrui Pharma Prices Hong Kong IPO at Top of Range, Raises HK$9.9 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2537981750","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537981750?lang=en_us&edition=fundamental","pubTime":"2025-05-21 18:29","pubTimestamp":1747823369,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  priced its initial public offering in Hong Kong at the upper limit of its indicative range to raise HK$9.89 billion.The Chinese drugmaker issued 224.5 million shares at HK$44.05 each, the top end of its guidance of as low as HK$41.45 per share, according to a Wednesday filing with the Hong Kong Exchange.The pharmaceutical company intends to disclose the allocation results of its secondary listing on May 22, Thursday, and begin trading on the Hong Kong bourse on May 23, Friday.The deal follows CATL's  over HK$35 billion share sale, reportedly the world's largest listing this year, according to Reuters.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"e862b389bed90f55480f427a9160eca9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01276","BK0188","LU1064131003.USD","BK0196","LU1064130708.USD","LU2148510915.USD","BK0239","LU0405327148.USD","LU1328615791.USD","LU2328871848.SGD","BK0183","LU1969619763.USD","600276","LU2488822045.USD","BK0060","BK0012","BK0028","LU0405327494.USD"],"gpt_icon":1},{"id":"1161533618","title":"Hengrui Pharma IPO Said To Be Priced At Upper Limit Of HKD44.05","url":"https://stock-news.laohu8.com/highlight/detail?id=1161533618","media":"aastocks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161533618?lang=en_us&edition=fundamental","pubTime":"2025-05-21 10:54","pubTimestamp":1747796063,"startTime":"0","endTime":"0","summary":"China's innovative pharmaceutical company, HENGRUI PHARMA  will raise $9.89 billion in its IPO at a cap offer price of $44.05, IFR quoted sources as saying.It was previously rumored that, due to strong demand for IPO subscription, HENGRUI PHARMA would close institutional investor subscriptions a day early at 5 PM on Monday . It is reported that institutional investor demand has topped the entire offering size.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"00417d1c9fabb8d35421e92b7c290bbb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/en/","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Hengrui Pharma IPO Said To Be Priced At Upper Limit Of HKD44.05","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1657595521938","symbols":["01276"],"gpt_icon":1},{"id":"2535892024","title":"Hong Kong Shares Snap Three-Day Winning Streak; Gold Shares Slide on Lower Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2535892024","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535892024?lang=en_us&edition=fundamental","pubTime":"2025-05-15 16:48","pubTimestamp":1747298938,"startTime":"0","endTime":"0","summary":"Hong Kong stocks fell Thursday following a three-day winning streak, as a rally led by a US-China trade truce lost steam, while lackluster earnings from Tencent further dampened sentiment.The Hang Sen","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HTCD.SI","LU0203345920.USD","01276","TCHmain","LU0543330483.HKD","SG9999001689.USD","LU0011963245.USD","LU0231483743.USD","LU1880383366.USD","LU1282651121.HKD","SG9999001069.SGD","BK1592","ALBmain","LU0359201612.USD","SCMP","LU1235295612.USD","MHImain","SG9999013353.USD","LU0594300179.USD","SG9999014898.SGD","HBBD.SI","MCHmain","HSI","02833","513600","02629","89988","LU0823397285.USD","02899","LU1282648689.USD","00700","IE00B031J352.USD","BK1594","BK4576","LU0823413660.USD","LU0561508036.HKD","HHImain","LU0067412154.USD","LU0577902454.USD","LU0214875030.USD","LU1008478684.HKD","LU1720051017.SGD","LU0499858602.USD","BK1544","SG9999001093.SGD","LU2357305700.SGD"],"gpt_icon":1},{"id":"2535785811","title":"Jiangsu Hengrui Pharmaceuticals Launches Up to HK$9.9 Billion Hong Kong IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2535785811","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535785811?lang=en_us&edition=fundamental","pubTime":"2025-05-15 10:46","pubTimestamp":1747277211,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  launched its initial public offering in Hong Kong Thursday, seeking to raise up to HK$9.89 billion from the deal.The drug company, listed in Shanghai since 2000, is offering up to 224,519,800 shares expected to be priced between HK$41.45 and HK$44.05 per share, according to a Thursday filing with the Hong Kong bourse.Jiangsu Hengrui expects to determine the IPO price on May 21 and disclose allocation results on May 22. Shares will begin trading on the stock exchange on May 23.The drug company intends to use the proceeds to fund its research and development initiatives, support the construction and upgrade of production and research facilities in China and overseas, and for working capital.Jiangsu Hengrui attracted Singaporean sovereign wealth fund GIC, Invesco, UBS AM Singapore, Cordial Solar, Hillhouse, Millennium Capital Management , and Oaktree as cornerstone investors.Morgan Stanley Asia, Citigroup Global Markets Asia, Citigroup Global Markets, Huat","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"91e99cfe11df70be5eb419835b6d886a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1989772840.SGD","LU1732800096.USD","BK4534","LU1969619763.USD","LU1720051017.SGD","LU2488822045.USD","LU1064131003.USD","LU1732799900.SGD","LU0314104364.USD","BK4585","LU2133065610.SGD","LU2028103732.USD","LU2271345857.HKD","LU0320765646.SGD","LU0006306889.USD","LU1162221912.USD","LU1720051108.HKD","LU1548497426.USD","BK0196","BK0028","LU0158827948.USD","LU2111349929.HKD","BK0183","BK4581","LU0106831901.USD","LU0405327148.USD","LU1363072403.SGD","LU2023251221.USD","LU0106261372.USD","BK4516","LU1668664300.SGD","LU0267386448.USD","LU0795875086.SGD","BK0239","LU0795875169.SGD","LU2089283258.USD","600276","LU1064130708.USD","01276","BK0188","LU2089284900.SGD","LU1989772923.USD","IE00BZ1G4Q59.USD","LU0225283273.USD","LU2347655156.SGD","BK4127","IE00BKVL7J92.USD","LU2148510915.USD","LU1328615791.USD","LU2328871848.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3182,"buy":0.4091,"hold":0.2273,"sell":0.0455,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4091,"analysts":22,"updateTime":1743523200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2025-05-23","current":52.570963,"percent":0,"low":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"high":53.632028,"avg":53.101495,"sd":0.530532,"marketCap":390693388207.53},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53}],"updateTime":1748191642567}}}